In addition to their role in RA, certain novel targets, such as RASGRP1 and PRKCB exhibit high expression in brain tissues, implicating them in neuroinflammatory processes and suggesting genetic overlap between RA and Alzheimer’s disease [70]. Here, PRKCB is linked to early-onset autosomal dominant Alzheimer disease.